CD19 and neoplasm: Lacking the pro-apoptotic signaling molecules BH3-interacting domain death agonist (BID) or fas-associated protein with death domain (FADD), B-ALL cells were resistant to CD19 CAR T cytotoxicity, leading to disease progression in mice, persistence of tumor cells, which exacerbated T cell dysfunction.